Original Article
Phase I study of afatinib plus bevacizumab in patients with advanced non-squamous non-small cell lung cancer harboring EGFR mutations
Ryo Ko, Takehito Shukuya, Chiyo K. Imamura, Takaaki Tokito, Naoko Shimada, Ryo Koyama, Kazuhiko Yamada, Hidenobu Ishii, Koichi Azuma, Kazuhisa Takahashi